GHP Investment Advisors’s Fulgent Genetics FLGT Stock Holding History

GHP Investment Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-510	Closed	-$8.62K	–	974
2025 Q1	$8.62K	Buy	510 +39	+8%	+$664	﹤0.01%	708
2024 Q4	$8.7K	Buy	471 +418	+789%	+$8.16K	﹤0.01%	720
2024 Q3	$1.15K	Hold	53	–	–	﹤0.01%	906
2024 Q2	$1.04K	Hold	53	–	–	﹤0.01%	895
2024 Q1	$1.15K	Hold	53	–	–	﹤0.01%	778
2023 Q4	$1.53K	Hold	53	–	–	﹤0.01%	772
2023 Q3	$1.32K	Hold	53	–	–	﹤0.01%	869
2023 Q2	$1.73K	Hold	53	–	–	﹤0.01%	840
2023 Q1	$1.66K	Hold	53	–	–	﹤0.01%	835
2022 Q4	$1.58K	Hold	53	–	–	﹤0.01%	848
2022 Q3	$2K	Hold	53	–	–	﹤0.01%	831
2022 Q2	$3K	Hold	53	–	–	﹤0.01%	824
2022 Q1	$3K	Buy	+53	New	+$3.49K	﹤0.01%	856

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GHP Investment Advisors's FLGT Position: Q2 2025 in Review

GHP Investment Advisors sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 510 shares — an estimated $8.62K sold.

GHP Investment Advisors first reported a position in FLGT in Q1 2022 and held it in 13 quarters. The position peaked at $8.7K in Q4 2024. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

GHP Investment Advisors reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
GHP Investment Advisors sold 510 Fulgent Genetics shares in Q2 2025, an estimated $8.62K.
GHP Investment Advisors first reported a position in Fulgent Genetics in Q1 2022 and held it in 13 quarters.
GHP Investment Advisors's Fulgent Genetics position peaked at $8.7K in Q4 2024.
167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on GHP Investment Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.